Autoimmune bullous diseases: diagnosis and management.
Autoimmune bullous diseases are a heterogenous group of diseases characterized by cutaneous and mucosal vesicles and bullae. Diagnosis is based on a combination of clinical, histopathological, and immunofluorescence findings. Current treatment, including vigilant wound care, significantly reduces disease morbidity and mortality.
McCuin
Jill B
JB
University of Cincinnati Medical Center, Cincinnati, OH, USA.
Hanlon
Terri
T
Mutasim
Diya F
DF
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D003937:Diagnosis, Differential; D016107:Epidermolysis Bullosa Acquisita / Q000175:diagnosis / Q000628:therapy; D005455:Fluorescent Antibody Technique; D006801:Humans; D017098:IgA Deficiency / Q000150:complications; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009730:Nursing Assessment; D010257:Paraneoplastic Syndromes / Q000150:complications; D010390:Pemphigoid, Benign Mucous Membrane / Q000175:diagnosis / Q000628:therapy; D010391:Pemphigoid, Bullous / Q000175:diagnosis / Q000628:therapy; D010392:Pemphigus / Q000175:diagnosis / Q000628:therapy; D017893:Photopheresis; D010956:Plasmapheresis; D017592:Skin Care / Q000379:methods / Q000451:nursing; D012872:Skin Diseases, Vesiculobullous / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents